Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the ...

Sedgwick brand protection has launched the first Australian edition of its Recall Index, which tracks product recalls and regulatory developments across five major industries.

The clinical hold was placed on three studies investigating azenosertib in June after two patients died due to presumed ...

Data demonstrate broad activity of CBX-12 across six tumor types with a strong response rate in TOP1-naïve patients with ovarian (40%; N=10) and ...

Design clinical trials with outcome measures appropriate for the at-risk state that effectively evaluate potential therapeutic targets for prevention as well as treat symptom complexes that may be ...

Choosing an index is not obvious, so here are a few essential questions that can help in the choice of an index. They are mainly applicable for L2 distances. We indicate: the index_factory string for ...

Each belongs to a group of approaches. While some mental health professionals work with only one group of approaches, other professionals are more flexible and take an integrative therapeutic approach ...

In this case, the Nrf2 inhibitors can be used along with factors affecting HCC survival to finally improve the selectivity and therapeutic index in HCC elimination. In order to provide a milestone in ...